About Seevix
Seevix is a company based in Jerusalem (Israel) founded in 2014. Seevix offers products and services including SVX, SpheroSeev, and HydroSeev. Seevix operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Jerusalem, Israel
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website seevix.com
- Social LinkedIn X
- InvestorsEuropean Union
& 1 more
Products & Services of Seevix
Seevix offers a comprehensive portfolio of products and services, including SVX, SpheroSeev, and HydroSeev.
Biopolymer inspired by spidersilk to enhance product strength and sustainability.
Tool for improving 3D cell culture applications in biotechnology.
System that enhances 3D cell culture for medical and research uses.
Funding Insights of Seevix
- Total Rounds 2
- First Round $61,347
(Mar 2018)
- Investors Count 2
All 2 funding rounds of Seevix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | – | Seed | – | ASICS Corporation | – |
| Mar 2018 | $61,347 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Seevix
Seevix has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and ASICS Corporation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Brand of sportswear | 1949 | corp.asics.com | Japan | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Seevix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Seevix
5 people are tracked at Seevix (4 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Shlomzion S. | Co-founder and CEO | Leadership |
Shmulik Ittah | Co-founder and scientific advisor | Leadership |
Alon Meir | Chief Scientist | Leadership |
Kosta Press | VP Product Development | Leadership |
David Mock | Private Investor And Fund Raiser | Team |
Complete people profiles for Seevix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Seevix
3 dated milestones of Seevix across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Seevix is founded.
- Funding First funding round of $61K.
- Funding Latest funding round, Seed,.
Competitors of Seevix
Seevix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| lifeminetx.com | 2016 | Cambridge, United States | $300.07M | 85 | Developer of novel drugs from fungi via genome mining and recombinant overexpression |
Detailed competitors of Seevix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Seevix
Complete news archive for Seevix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Seevix
10 companies that operate in the same segment as Seevix (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Seevix
Seevix was founded in 2014 and raised its 1st funding round 4 years after it was founded.
Seevix is headquartered in Jerusalem, Israel. It is registered at Jerusalem, Jerusalem District, Israel.
Seevix was established in 2014 in Jerusalem, Israel, within the biotechnology and materials sector. Patented genetic engineering techniques are applied to create spider silk fibers that match natural counterparts. These fibers function as substitutes for Kevlar and steel in high-tensile roles. A proprietary one-step manufacturing process is utilized for scalable production, which shortens timelines and lowers expenses. Operations focus on supplying materials to diverse industries.
Seevix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Seevix offers SVX, SpheroSeev, and HydroSeev.
Seevix has 2 investors. Key investors include European Union, and ASICS Corporation.